Showing results (221-230 of 276) with videos related to

Sort By:
Pageof 28
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in MiceLinda N Broer, Daan G Knapen, Frans V Suurs, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 2006
Lysosomal storage diseases in non-immune hydrops fetalis pregnanciesAngelique J A Kooper, Pim M W Janssens, Akosua N J A de Groot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemiaMariël L te Winkel, Rob Pieters, Wim C J Hop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 ProbodyLaura Kist de Ruijter, Jahlisa S Hooiveld-Noeken, Danique Giesen, et al.
Bone|November 30, 2013
Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocolMariël L te Winkel, Rob Pieters, Wim C J Hop, et al.
International Journal of Medical Informatics|March 28, 2019
Conversion of STOPP/START version 2 into coded algorithms for software implementation: A multidisciplinary consensus procedureCorlina J A Huibers, Bastiaan T G M Sallevelt, Dominique A de Groot, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre studyKarin G E Miedema, Wim J E Tissing, Floor C H Abbink, et al.
Cancer Discovery|June 9, 2022
Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid NeoplasmsEline J M Bertrums, Axel K M Rosendahl Huber, Jurrian K de Kanter, et al.
Molecular Oncology|July 28, 2019
RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancerErik J van Helden, Lindsay Angus, C Willemien Menke-van der Houven van Oordt, et al.
Haematologica|October 12, 2014
The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemiaMarissa A H den Hoed, Saskia M F Pluijm, Hester A de Groot-Kruseman, et al.
Pageof 28